Market Overview:
The global diagnostic and interventional cardiology devices market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cardiovascular diseases, technological advancements in diagnostic and interventional cardiology devices, and rising demand for minimally invasive procedures. The global diagnostic and interventional cardiology devices market is segmented on the basis of type into transcatheter angiography devices, intravascular ultrasound (IVUS) devices, guide wire-based intravascular stenosis assessment or fractional flow reserve (FFR)devices, intracardiac echocardiography (ICE)devices, optical coherence tomography (OCT)devices, and robotic-assisted surgical devices. The transcatheter angiography device segment is expected to dominate the global diagnostic and interventional cardiology device market during the forecast period owing to its high usage in percutaneous coronary interventions (PCI). The ICE device segment is projected to grow at a highest CAGR during the forecast period due to its growing usage for diagnosis of heart failure.
Product Definition:
The term "diagnostic and interventional cardiology devices" generally refers to any medical device that is used in the diagnosis or treatment of cardiovascular disease. Examples of such devices include cardiac catheters, stents, and pacemakers. The use of these devices can be life-saving in many cases, and they have become increasingly common in recent years.
Transcatheter Angiography Devices:
Transcatheter angiography (TSA) is a minimally invasive procedure used to evaluate coronary and peripheral artery disease. It allows real-time, three-dimensional imaging of blood vessels during the injection of contrast media into the bloodstream. The technology has been available for more than a decade but its clinical implementation was limited due to high costs and technological limitations until recently when these issues were overcome by improved manufacturing techniques and FDA approval for several SA devices in 2014.
Intravascular Ultrasound (IVUS) Devices:
Intravascular ultrasound (IVUS) devices are used to evaluate the blood vessels in the body. It is a noninvasive medical imaging technique that uses high-frequency sound waves to create images of blood vessels and other tissues within the body. IVUS works by detecting vessel walls via reflected ultrasound beams, which bounce off of internal and external surfaces of blood vessels.
Application Insights:
Based on application, the global market is segmented into hospitals and specialty clinics. Hospitals held the largest share in 2017 owing to factors such as a high prevalence of cardiovascular diseases requiring treatment and an increase in hospital admissions for these conditions. According to data published by WHO, around 31% of deaths occur due to CVDs globally, with China having the highest number of deaths due to CVDs followed by Russia. Thus, increasing healthcare expenditure coupled with a high prevalence rate is expected to drive demand for diagnostics & interventional cardiac devices in hospitals over the forecast period.
Specialty clinics are anticipated register significant growth during the forecast period owing to an increase in patient awareness regarding minimally invasive surgeries and availability of advanced equipment that helps deliver better results at lesser costs compared with conventional surgery procedures. Moreover, technological advancements such as introduction of novel imaging techniques that help identify structural heart problems are likely further boost product demand at these facilities over next seven years.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of well-established healthcare facilities, availability of advanced devices, and high adoption rate for new technologies. Moreover, increasing prevalence of cardiac disorders is also expected to drive regional growth during the forecast period. For instance, according to a study published by National Center for Health Statistics (NCHS), in U.S., around 695 thousand people died due to coronary heart diseases (CHD) in 2016 which was approximately 1% higher than 2015 and 3% higher than 2014.
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs)
- Growing geriatric population
- Rising demand for minimally invasive procedures
- Technological advancements in diagnostic and interventional cardiology devices
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Diagnostic and Interventional Cardiology Devices Market Research Report
By Type
Transcatheter Angiography Devices, Intravascular Ultrasound (IVUS) Devices, Guide Wire-Based Intravascular Stenosis Assessment Or Fractional Flow Reserve (FFR) Devices, Intracardiac Echocardiography (ICE) Devices, Optical Coherence Tomography (OCT) Devices, Robotic-Assisted Surgical Devices
By Application
Hospitals, Specialty Clinics
By Companies
Bracco, Auris Surgical Robotics Inc., B. Braun Medical (B. Braun Melsungen), Biosense Webster Inc. (Johnson & Johnson), Boston Scientific Corp., Catheter Precision, Cook Medical, Corindus Vascular Robotics Inc.(Siemens Healthcare), GE Healthcare, Hansen Medical Inc., Kaiser Permanente, Abbott Cardiovascular, C.R. Bard, Covidien, Edwards Lifescience, Johnson & Johnson, Medtronic, Plc Medical Systems
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
204
Number of Tables & Figures
143
Customization Available
Yes, the report can be customized as per your need.
Global Diagnostic and Interventional Cardiology Devices Market Report Segments:
The global Diagnostic and Interventional Cardiology Devices market is segmented on the basis of:
Types
Transcatheter Angiography Devices, Intravascular Ultrasound (IVUS) Devices, Guide Wire-Based Intravascular Stenosis Assessment Or Fractional Flow Reserve (FFR) Devices, Intracardiac Echocardiography (ICE) Devices, Optical Coherence Tomography (OCT) Devices, Robotic-Assisted Surgical Devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Specialty Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bracco
- Auris Surgical Robotics Inc.
- B. Braun Medical (B. Braun Melsungen)
- Biosense Webster Inc. (Johnson & Johnson)
- Boston Scientific Corp.
- Catheter Precision
- Cook Medical
- Corindus Vascular Robotics Inc.(Siemens Healthcare)
- GE Healthcare
- Hansen Medical Inc.
- Kaiser Permanente
- Abbott Cardiovascular
- C.R. Bard
- Covidien
- Edwards Lifescience
- Johnson & Johnson
- Medtronic
- Plc Medical Systems
Highlights of The Diagnostic and Interventional Cardiology Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Transcatheter Angiography Devices
- Intravascular Ultrasound (IVUS) Devices
- Guide Wire-Based Intravascular Stenosis Assessment Or Fractional Flow Reserve (FFR) Devices
- Intracardiac Echocardiography (ICE) Devices
- Optical Coherence Tomography (OCT) Devices
- Robotic-Assisted Surgical Devices
- By Application:
- Hospitals
- Specialty Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diagnostic and Interventional Cardiology Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Diagnostic and interventional cardiology devices are medical devices used to diagnose and treat heart conditions. These devices can include stents, pacemakers, defibrillators, and other medical equipment.
Some of the key players operating in the diagnostic and interventional cardiology devices market are Bracco, Auris Surgical Robotics Inc., B. Braun Medical (B. Braun Melsungen), Biosense Webster Inc. (Johnson & Johnson), Boston Scientific Corp., Catheter Precision, Cook Medical, Corindus Vascular Robotics Inc.(Siemens Healthcare), GE Healthcare, Hansen Medical Inc., Kaiser Permanente, Abbott Cardiovascular, C.R. Bard, Covidien, Edwards Lifescience, Johnson & Johnson, Medtronic, Plc Medical Systems.
The diagnostic and interventional cardiology devices market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Diagnostic and Interventional Cardiology Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Diagnostic and Interventional Cardiology Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Diagnostic and Interventional Cardiology Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Diagnostic and Interventional Cardiology Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Diagnostic and Interventional Cardiology Devices Market Size & Forecast, 2018-2028
4.5.1 Diagnostic and Interventional Cardiology Devices Market Size and Y-o-Y Growth
4.5.2 Diagnostic and Interventional Cardiology Devices Market Absolute $ Opportunity
Chapter 5 Global Diagnostic and Interventional Cardiology Devices Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Diagnostic and Interventional Cardiology Devices Market Size Forecast by Type
5.2.1 Transcatheter Angiography Devices
5.2.2 Intravascular Ultrasound (IVUS) Devices
5.2.3 Guide Wire-Based Intravascular Stenosis Assessment Or Fractional Flow Reserve (FFR) Devices
5.2.4 Intracardiac Echocardiography (ICE) Devices
5.2.5 Optical Coherence Tomography (OCT) Devices
5.2.6 Robotic-Assisted Surgical Devices
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Diagnostic and Interventional Cardiology Devices Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Diagnostic and Interventional Cardiology Devices Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Specialty Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Diagnostic and Interventional Cardiology Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Diagnostic and Interventional Cardiology Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Diagnostic and Interventional Cardiology Devices Analysis and Forecast
9.1 Introduction
9.2 North America Diagnostic and Interventional Cardiology Devices Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Diagnostic and Interventional Cardiology Devices Market Size Forecast by Type
9.6.1 Transcatheter Angiography Devices
9.6.2 Intravascular Ultrasound (IVUS) Devices
9.6.3 Guide Wire-Based Intravascular Stenosis Assessment Or Fractional Flow Reserve (FFR) Devices
9.6.4 Intracardiac Echocardiography (ICE) Devices
9.6.5 Optical Coherence Tomography (OCT) Devices
9.6.6 Robotic-Assisted Surgical Devices
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Diagnostic and Interventional Cardiology Devices Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Specialty Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Diagnostic and Interventional Cardiology Devices Analysis and Forecast
10.1 Introduction
10.2 Europe Diagnostic and Interventional Cardiology Devices Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Diagnostic and Interventional Cardiology Devices Market Size Forecast by Type
10.6.1 Transcatheter Angiography Devices
10.6.2 Intravascular Ultrasound (IVUS) Devices
10.6.3 Guide Wire-Based Intravascular Stenosis Assessment Or Fractional Flow Reserve (FFR) Devices
10.6.4 Intracardiac Echocardiography (ICE) Devices
10.6.5 Optical Coherence Tomography (OCT) Devices
10.6.6 Robotic-Assisted Surgical Devices
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Diagnostic and Interventional Cardiology Devices Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Specialty Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Diagnostic and Interventional Cardiology Devices Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Diagnostic and Interventional Cardiology Devices Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Diagnostic and Interventional Cardiology Devices Market Size Forecast by Type
11.6.1 Transcatheter Angiography Devices
11.6.2 Intravascular Ultrasound (IVUS) Devices
11.6.3 Guide Wire-Based Intravascular Stenosis Assessment Or Fractional Flow Reserve (FFR) Devices
11.6.4 Intracardiac Echocardiography (ICE) Devices
11.6.5 Optical Coherence Tomography (OCT) Devices
11.6.6 Robotic-Assisted Surgical Devices
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Diagnostic and Interventional Cardiology Devices Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Specialty Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Diagnostic and Interventional Cardiology Devices Analysis and Forecast
12.1 Introduction
12.2 Latin America Diagnostic and Interventional Cardiology Devices Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Diagnostic and Interventional Cardiology Devices Market Size Forecast by Type
12.6.1 Transcatheter Angiography Devices
12.6.2 Intravascular Ultrasound (IVUS) Devices
12.6.3 Guide Wire-Based Intravascular Stenosis Assessment Or Fractional Flow Reserve (FFR) Devices
12.6.4 Intracardiac Echocardiography (ICE) Devices
12.6.5 Optical Coherence Tomography (OCT) Devices
12.6.6 Robotic-Assisted Surgical Devices
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Diagnostic and Interventional Cardiology Devices Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Specialty Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Diagnostic and Interventional Cardiology Devices Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Diagnostic and Interventional Cardiology Devices Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Diagnostic and Interventional Cardiology Devices Market Size Forecast by Type
13.6.1 Transcatheter Angiography Devices
13.6.2 Intravascular Ultrasound (IVUS) Devices
13.6.3 Guide Wire-Based Intravascular Stenosis Assessment Or Fractional Flow Reserve (FFR) Devices
13.6.4 Intracardiac Echocardiography (ICE) Devices
13.6.5 Optical Coherence Tomography (OCT) Devices
13.6.6 Robotic-Assisted Surgical Devices
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Diagnostic and Interventional Cardiology Devices Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Specialty Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Diagnostic and Interventional Cardiology Devices Market: Competitive Dashboard
14.2 Global Diagnostic and Interventional Cardiology Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bracco
14.3.2 Auris Surgical Robotics Inc.
14.3.3 B. Braun Medical (B. Braun Melsungen)
14.3.4 Biosense Webster Inc. (Johnson & Johnson)
14.3.5 Boston Scientific Corp.
14.3.6 Catheter Precision
14.3.7 Cook Medical
14.3.8 Corindus Vascular Robotics Inc.(Siemens Healthcare)
14.3.9 GE Healthcare
14.3.10 Hansen Medical Inc.
14.3.11 Kaiser Permanente
14.3.12 Abbott Cardiovascular
14.3.13 C.R. Bard
14.3.14 Covidien
14.3.15 Edwards Lifescience
14.3.16 Johnson & Johnson
14.3.17 Medtronic
14.3.18 Plc Medical Systems
